Form 8.3: SPI LN

Summary by AI BETAClose X

Syquant Capital disclosed on Nov 11, 2026 that as at Nov 10, 2026 it holds a derivatives position of 8,448,121 Spire Healthcare 1p ordinary shares representing 2.09% of the share capital; the filing records the position via CFDs and an incremental trade increasing a long CFD by 505 reference securities at a price of 247.5 GBp. The disclosure states there are no direct holdings, no options or subscription rights, no indemnities or other arrangements, and no Supplemental Form 8 attached.

Disclaimer*

UK 100